TickerGuard
Buy Day today: Neutral (47) Mixed market breadth · no major macro event
KPTI

Karyopharm Therapeutics Inc

Healthcare · Biotechnology

0.645$ -0.8% vs. previous close Closing price · As of: Oct 7, 2026

Statements

Balance Sheet

Karyopharm Therapeutics Inc (KPTI) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 111 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size %
Last 12 Full history
Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet KPTI
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
184 180 155 186 164 180 146 257 220 341 287 238 298 295 416 380 338 313 275 287 254 305 294 256 231 358 326 298 270 240 204 214 189 164 128 105 96 108 131 111
130 132 112 146 122 148 133 245 212 335 271 223 281 274 371 318 285 290 256 274 242 276 277 242 223 350 297 291 263 234 198 209 185 156 120 98 90 103 126 106
44 50 26 55 54 69 37 119 102 118 84 76 168 129 202 103 82 86 88 141 137 190 153 82 71 135 84 81 44 52 31 85 73 62 39 39 38 61 91 55
127 130 110 143 119 146 131 241 207 328 264 217 268 264 352 297 263 273 224 236 204 229 205 171 148 278 260 237 208 191 149 152 134 109 70 52 46 64 91 65
– – – – – – – – – – – – 7.9 7.9 9.3 9.6 11 13 18 18 19 22 25 23 27 47 35 32 38 27 31 38 32 31 35 33 32 26 23 30
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 – – – 0.1 0.3 1.0 1.7 2.0 2.6 3.1 3.9 3.9 4.1 3.9 3.5 4.2 4.2 3.8 3.7 3.1 3.0 2.8 3.5 4.7 4.7 4.8 5.0 4.0 4.0 3.6 4.0
3.0 2.8 2.7 2.5 2.3 2.2 2.5 2.6 2.9 3.9 3.6 3.4 3.2 3.0 2.8 2.6 2.4 2.2 11 10 1.6 1.6 1.5 1.4 1.3 1.1 0.8 6.1 – – – – – – – – – – – –
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – –
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – –
17 18 17 19 23 51 51 43 49 158 166 156 238 245 250 250 254 263 315 370 380 385 377 373 372 375 371 369 370 377 373 346 349 350 334 344 365 401 397 441
15 16 15 18 21 49 47 37 42 47 44 32 39 46 50 51 53 0.3 62 58 69 74 66 63 62 66 62 59 62 69 65 58 61 92 90 99 87 92 117 134
– – – 13 18 22 22 23 29 33 1.4 1.5 1.6 1.6 1.7 1.8 1.8 1.9 2.0 2.1 2.2 2.3 2.5 2.6 2.8 2.9 3.0 3.1 3.2 3.3 3.4 3.5 3.7 25 25 32 14 22 33 1.1
2.2 4.8 4.2 3.2 1.9 5.7 4.9 3.8 2.2 4.3 2.3 1.1 3.1 1.0 1.7 1.9 2.4 4.5 3.0 2.3 0.9 1.6 3.4 1.7 0.8 2.8 9.0 2.3 0.9 3.1 5.0 2.8 5.8 5.1 5.9 2.6 5.4 4.0 4.3 7.7
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 103 104 106 108 110 112 114 116 118 169 169 169 169 169 170 170 170 170 170 171 171 171 191 191 163 155 152 177 206 192 210
167 162 138 167 141 129 96 213 171 183 121 82 60 50 166 130 84 51 -40 -83 -126 -80 -83 -116 -140 -17 -45 -71 -100 -136 -169 -132 -160 -186 -206 -239 -269 -293 -266 -330
-339 -366 -396 -426 -456 -495 -534 -567 -616 -674 -740 -783 -825 -873 -926 -973 -1,026 -1,070 -1,112 -1,166 -1,217 -1,179 -1,220 -1,269 -1,305 -1,344 -1,378 -1,411 -1,445 -1,487 -1,524 -1,501 -1,533 -1,563 -1,587 -1,624 -1,657 -1,759 -1,782 -1,849
2.5 2.8 2.8 3.1 3.1 3.2 3.3 3.7 4.0 61 4.1 4.1 4.1 64 4.5 4.9 4.9 74 5.0 5.0 5.0 5.8 5.2 5.3 5.3 6.0 113 7.6 7.6 7.7 7.7 10 8.3 8.4 8.5 8.6 8.7 18 25 29

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?